Currently, the K Virus Therapy has only one auxiliary factor, and the next focus of work is to obtain more auxiliary factors. The present auxiliary factor—the K factor—has good effects only on a few types of tumors. If more factors can be developed, the scope of the K Virus Therapy can be broadened. One day, if similar K factors for all tumors can be found, it will be possible to treat all tumors. Of course, this is just a beautiful vision, and realizing it will require a long, long journey.
Ruixing Medical's trial installation of the K biological agent has begun. Like ordinary biological agents, it uses cold chain transportation, ready to use upon opening, making it very convenient and much more convenient than cell therapy.
A new medicine, new equipment, a new treatment method has a much larger impact compared to surgery. A surgery can only save one person, but a new method can save countless people.
